期刊文献+

MMP-2和MMP-9在多发性肌炎/皮肌炎患者单一核细胞中的表达

Expression of matrix metalloproteinase-2 and -9 in the PBMC of patients with polymyositis and dermatomyositis
原文传递
导出
摘要 目的探讨基质金属蛋白酶MMP-2和MMP-9与多发性肌炎,皮肌炎(PM/DM)的关系。方法采用实时荧光定量PCR和Western印迹方法分别检测PM/DM患者外周血单一核细胞(PMBC)中MMP-2和MMP-9的mRNA和蛋白表达水平。结果MMP-2、MMP-9在PM/DM患者外周血PMBC中的mRNA表达水平明显高于正常人对照组,其中MMP-2为正常人对照组的2.41倍、MMP-9则为1.66倍。Western印迹检测发现MMP-2、MMP-9在PM,DM患者外周血PMBC中的蛋白表达水平也明显高于正常人对照组,与其mRNA表达结果一致。结论基质金属蛋白酶MMP-2和MMP-9可能在PM/DM的发生中起作用。 Objective To investigate the relation of the expressions of matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) with polymyositis/dermatomyositis (PM/DM). Methods Blood samples were obtained from 8 patients with PM, 12 patients with DM and l0 normal human controls. Real-time quantitative RT-PCR and Western-blot were applied to examine the mRNA and protein expressions of MMP-2 and MMP-9 respectively in the peripheral blood mononuclear cells (PBMC) of these patients. Results The mRNA expression levels of MMP-2 and MMP-9 in the PBMC of patients with PM or DM were 2.41 and 1.66 folds as high as those of the normal controls, respectively; these differences were significant between the two groups. Increased expressions of MMP-2 and MMP-9 were also noted in the patients with PM or DM. Conclusion MMP-2 and MMP-9 may play a part in the development of polymyositis and dermatomyositis.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2008年第6期397-399,共3页 Chinese Journal of Dermatology
基金 湖南省科学技术厅科技计划基金(06FJ3150)
关键词 多发性肌炎 皮肌炎 基质金属蛋白酶2 基质金属蛋白酶9 Polymyositis Dermatomyositis Matrix metalloproteinase 2 Matrix metalloproteinase 9
  • 相关文献

参考文献10

  • 1Heffner RR. Inflammatory myopathies A review. J Neuropathol Exp Neurol, 1993, 52(4): 339-350.
  • 2Plotz PH, DaladasM, Left RL, et al. Current concepts in the idiopathic inflammatorymyopathies: polymyositis, dematomvositis, and related disorders. Ann Intern ged, 1989, 111(2): 143-157.
  • 3杨荫昌 杨谦贤 等.单纯性多发性肌炎-23例临床观察[J].中华神经精神科杂志,1983,16:340-340.
  • 4Koh ET, Ong B. Adult pdym-yositis/dermatomyositis; clinical and laboratory features and treatment response in 75 patients. Ann Rheum Dis, 1993, 52: 857-861.
  • 5Ram M, Sherer Y, Shoenfeld Y. Matrix metalloproteinase-9 and autoimmune diseases. J Clin Immunol, 2006, 26(4): 299-307.
  • 6Smit s HH, de Jong EC, Schuitemaker J HN, et al. Intercellular Adhesion Molecule-1/LFA-I Ligation Favors HumanThl Development. J Immunol, 2002, 168(4): 1710-1716.
  • 7Livak KJ, Schmittgen TD. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2^-ΔΔCT Method. Methods, 2001, 25: 402-408.
  • 8Rouhiainen A, Imai S, Rauvala H, et al. Occurrence of amphoterin (HMGBI) as an endogenous protein of human platelets that is exported to the cell surface upon platelet activation. Thromb Haemost, 2000, 84: 1087-1094.
  • 9Rodolico C, Mazzeo A, Toscano A, et al. Specific matrix metalloproteinase expression in focal myositis: an immunopathological study. Acta Neurol Scand, 2005, 112(3): 173-177.
  • 10Schoser BG, Blottner D, Stuerenburg HJ. Matrix metalloproteinases in inflammatory myopathies: enhanced immunoreactivity near atrophic myofibers. Acta Neurol Scand, 2002, 105 (4): 309-313.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部